252 related articles for article (PubMed ID: 31245977)
21. En Face Optical Coherence Tomography Imaging of the Photoreceptor Layers in Hydroxychloroquine Retinopathy.
Ahn SJ; Joung J; Lee BR
Am J Ophthalmol; 2019 Mar; 199():71-81. PubMed ID: 30448463
[TBL] [Abstract][Full Text] [Related]
22. [Chloroquine/hydroxychloroquine: variability of retinotoxic cumulative doses].
Rüther K; Foerster J; Berndt S; Schroeter J
Ophthalmologe; 2007 Oct; 104(10):875-9. PubMed ID: 17653725
[TBL] [Abstract][Full Text] [Related]
23. The Diagnostic Utility of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity.
Tsang AC; Ahmadi S; Hamilton J; Gao J; Virgili G; Coupland SG; Gottlieb CC
Am J Ophthalmol; 2019 Oct; 206():132-139. PubMed ID: 31078540
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of Hydroxychloroquine Retinopathy Using Ultra-Widefield Fundus Autofluorescence: Peripheral Findings in the Retinopathy.
Ahn SJ; Joung J; Lee BR
Am J Ophthalmol; 2020 Jan; 209():35-44. PubMed ID: 31526798
[TBL] [Abstract][Full Text] [Related]
25. Effect of disease stage on progression of hydroxychloroquine retinopathy.
Marmor MF; Hu J
JAMA Ophthalmol; 2014 Sep; 132(9):1105-12. PubMed ID: 24922444
[TBL] [Abstract][Full Text] [Related]
26. Optical coherence tomography in a patient with chloroquine-induced maculopathy.
Korah S; Kuriakose T
Indian J Ophthalmol; 2008; 56(6):511-3. PubMed ID: 18974527
[TBL] [Abstract][Full Text] [Related]
27. Effects of chronic exposure to hydroxychloroquine or chloroquine on inner retinal structures.
Pasadhika S; Fishman GA
Eye (Lond); 2010 Feb; 24(2):340-6. PubMed ID: 19373270
[TBL] [Abstract][Full Text] [Related]
28. Long-Term Progression of Pericentral Hydroxychloroquine Retinopathy.
Ahn SJ; Seo EJ; Kim KE; Kim YJ; Lee BR; Kim JG; Yoon YH; Lee JY
Ophthalmology; 2021 Jun; 128(6):889-898. PubMed ID: 33129843
[TBL] [Abstract][Full Text] [Related]
29. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.
Marmor MF; Kellner U; Lai TY; Lyons JS; Mieler WF;
Ophthalmology; 2011 Feb; 118(2):415-22. PubMed ID: 21292109
[TBL] [Abstract][Full Text] [Related]
30. Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine.
Kellner U; Renner AB; Tillack H
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3531-8. PubMed ID: 16877425
[TBL] [Abstract][Full Text] [Related]
31. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation.
Vujosevic S; Bottega E; Casciano M; Pilotto E; Convento E; Midena E
Retina; 2010 Jun; 30(6):908-16. PubMed ID: 20168272
[TBL] [Abstract][Full Text] [Related]
32. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).
Marmor MF; Kellner U; Lai TY; Melles RB; Mieler WF;
Ophthalmology; 2016 Jun; 123(6):1386-94. PubMed ID: 26992838
[TBL] [Abstract][Full Text] [Related]
33. Use of OCT Retinal Thickness Deviation Map for Hydroxychloroquine Retinopathy Screening.
Kim KE; Ahn SJ; Woo SJ; Park KH; Lee BR; Lee YK; Sung YK
Ophthalmology; 2021 Jan; 128(1):110-119. PubMed ID: 32553941
[TBL] [Abstract][Full Text] [Related]
34. Microperimetric correlations of autofluorescence and optical coherence tomography imaging in dry age-related macular degeneration.
Querques L; Querques G; Forte R; Souied EH
Am J Ophthalmol; 2012 Jun; 153(6):1110-5. PubMed ID: 22321805
[TBL] [Abstract][Full Text] [Related]
35. Optical coherence tomography angiography for screening of hydroxychloroquine-induced retinal alterations.
Bulut M; Akıdan M; Gözkaya O; Erol MK; Cengiz A; Çay HF
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2075-2081. PubMed ID: 30159602
[TBL] [Abstract][Full Text] [Related]
36. Early morpho-functional changes in patients treated with hydroxychloroquine: a prospective cohort study.
Ruberto G; Bruttini C; Tinelli C; Cavagna L; Bianchi A; Milano G
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2201-2210. PubMed ID: 30151601
[TBL] [Abstract][Full Text] [Related]
37. Microperimetry in hydroxychloroquine macular toxicity.
Durán-Carrasco OE; Rodríguez-Gil R; Pérez-Llombet-Quintana N; Fernández-Núñez C; Alberto-Pestano M; Alonso-Plasencia M; Abreu-González R
Rom J Ophthalmol; 2021; 65(3):235-240. PubMed ID: 35036643
[No Abstract] [Full Text] [Related]
38. Correlation of fundus autofluorescence gray values with vision and microperimetry in resolved central serous chorioretinopathy.
Oh J; Kim SW; Kwon SS; Oh IK; Huh K
Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):179-84. PubMed ID: 22159007
[TBL] [Abstract][Full Text] [Related]
39. Eight-year multimodal follow-up of recurrent idiopathic acute exudative polymorphous vitelliform maculopathy.
Astakhov YS; Astakhov SY; Lisochkina AB; Nechiporenko PA
J Fr Ophtalmol; 2020 Jun; 43(6):500-516. PubMed ID: 32147214
[TBL] [Abstract][Full Text] [Related]
40. Hydroxychloroquine Screening Alert: Change is in the Wind.
Marmor MF
Ophthalmic Surg Lasers Imaging Retina; 2017 Feb; 48(2):96-98. PubMed ID: 28195610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
